admin

More than 200 House Democrats voted against a bill aimed at criminalizing transgender medical treatment for minors Wednesday evening. The bill passed in a 216-211 vote that had some bipartisan crossover. Three Democrats — Vicente…

FBI Deputy Director Dan Bongino is leaving the bureau in January after speculation rose this week concerning his departure. ‘I will be leaving my position with the FBI in January,’ Bongino wrote in an X…

The House passed a bill on Wednesday that would criminalize gender transition treatment for minors. The measure, sponsored by Rep. Marjorie Taylor Greene, R-Ga., passed by a 216-211 vote with some bipartisan support. Reps. Henry…

Deputy FBI Director Dan Bongino, who announced on Wednesday that he will be departing from his role in January, later replied to FBI Director Kash Patel, who gave him a glowing review. ‘Dan is the…

Basin Energy (BSN:AU) has announced Completes phase one drilling and expands Sybella-Barkly Download the PDF here. This post appeared first on investingnews.com

The changes include new options for developers to distribute apps and process payments, and new protections to help reduce privacy and security risks the MSCA creates Apple® today announced changes impacting iOS apps in Japan…

American Uranium Limited (ASX:AMU, OTC:AMUIF) (American Uranium, AMU or the Company) is pleased to advise that 2025 resource expansion drilling at its Lo Herma ISR uranium project in Wyoming’s Powder River Basin (Lo Herma, the…

Group Eleven Resources Corp. (TSXV: ZNG,OTC:GRLVF) (OTCQB: GRLVF) (FSE: 3GE) (‘Group Eleven’ or the ‘Company’) announces that it has granted 2,600,000 incentive stock options to directors, officers and employees pursuant to the terms of the…

After a year marked by policy changes and trade uncertainty, experts are calling for cleantech investment to be dominated by artificial intelligence (AI) energy demand in the first quarter of 2026. The COP30 conference, held…

InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today confirmed that, at its…